Documents for Covaxin emergency use listing submitted to WHO; expect approval at earliest: Bharat Biotech

According to WHO guidelines, EUL is a procedure to streamline the process by which new or unlicensed products can be used during public health emergencies.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3xE9l56
via IFTTT